Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-005374
Filing Date
2017-11-03
Accepted
2017-11-03 15:33:30
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 198655
2 CERTIFICATION nbio_ex311.htm EX-31.1 7256
3 CERTIFICATION nbio_ex312.htm EX-31.2 7207
4 CERTIFICATION nbio_ex321.htm EX-32.1 2833
5 CERTIFICATION nbio_ex322.htm EX-32.2 2972
  Complete submission text file 0001477932-17-005374.txt   2073696

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20170930.xml EX-101.INS 336108
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20170930.xsd EX-101.SCH 43890
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20170930_cal.xml EX-101.CAL 31867
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20170930_def.xml EX-101.DEF 113740
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20170930_lab.xml EX-101.LAB 189971
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20170930_pre.xml EX-101.PRE 175129
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 171176252
SIC: 2834 Pharmaceutical Preparations